Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
European Journal of Preventive Cardiology|June 28, 2025
External validation of the Systematic Coronary Risk Evaluation 2 (SCORE2) and SCORE2-Older Persons in cancer patientsMari Nordbø Gynnild, Joris Holtrop, Steven H J Hageman, et al.
Atherosclerosis|August 10, 2024
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trialsPascal M Burger, Jannick A N Dorresteijn, Stefan Koudstaal, et al.
European Heart Journal|September 1, 2024
Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model, Steven H J Hageman, Zijuan Huang, et al.
International Journal of Cardiology|July 22, 2017
Decline in risk of recurrent cardiovascular events in the period 1996 to 2014 partly explained by better treatment of risk factors and less subclinical atherosclerosisGijs F N Berkelmans, Yolanda van der Graaf, Jannick A N Dorresteijn, et al.
European Journal of Preventive Cardiology|August 26, 2025
Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patientsJoris Holtrop, Mari Nordbø Gynnild, Toril Dammen, et al.
Clinical Kidney Journal|September 26, 2022
Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect predictionRob C M van Kruijsdijk, Robin W M Vernooij, Michiel L Bots, et al.
Journal of Clinical Epidemiology|January 23, 2022
Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practiceGijs F N Berkelmans, Stephanie H Read, Soffia Gudbjörnsdottir, et al.
European Journal of Clinical Nutrition|May 27, 2024
Dietary habits and compliance with dietary guidelines in patients with established cardiovascular diseaseNadia E Bonekamp, Johanna M Geleijnse, Yvonne T van der Schouw, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 4, 2022
Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes: 10-Year and Lifetime Risk Prediction ModelsHelena Bleken Østergaard, Stephanie H Read, Naveed Sattar, et al.
Pageof 7